Sponsor

Elcelyx Therapeutics, Inc.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Elcelyx Therapeutics, Inc. appears in 4 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials4
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

4 shown
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DMNCT02526524 · lead sponsor · 2015-09-01
COMPLETED
Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 WeeksNCT01819272 · lead sponsor · 2013-04-01
COMPLETED
Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DMNCT01804842 · lead sponsor · 2012-12-01
COMPLETED
Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DMNCT01677299 · lead sponsor · 2012-05-01
COMPLETED

Sponsor roles

lead sponsor4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.